AGILENT TECHNOLOGIES INC

Agilent insider trading insights reveal confidence amid growth—explore how exec moves, AI, and value‑based reimbursement drive life‑sciences innovation.

Agilent Technologies insider trading insights: May Simon sold 368 shares at $115.62, reflecting routine portfolio moves, while emerging oncology and antiviral therapies—like ADCs, pibrentasvir, and mRNA influenza vaccines—offer new treatment options…